The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Market Size and Growth

• 2023 Growth: The Sanger sequencing market reached $2.29 billion in 2023.
• 2024 Projection: It is expected to grow to $2.75 billion in 2024, reflecting a compound annual growth rate (CAGR) of 19.9%.
• 2028 Projection: By 2028, the market is projected to reach $5.30 billion, with a CAGR of 17.8%.

Drivers of Historic Growth

• Increased Research Demand: Growing research activities have fueled market expansion.
• Medical Diagnostics: Rising use in medical diagnostics has boosted market size.
• Pharmaceutical Development: Enhanced pharmaceutical development activities have contributed to growth.
• Agricultural Applications: Expanded use in agriculture for crop improvement and disease resistance.
• Forensic Analysis: Increasing forensic analysis needs.
• Biomarker Discovery: Growing importance of biomarkers in personalized medicine.
• Genetic Evolution Studies: Increasing studies on genetic evolution.

View More On The Sanger Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

Drivers of Future Growth

• Clinical Genomics Integration: Enhanced integration in clinical genomics.
• Agricultural Genomics Expansion: Broader applications in agricultural genomics.
• Drug Safety and Pharmacogenomics: Rising importance in drug safety and pharmacogenomics.
• Prenatal and Newborn Screening: Increasing use in prenatal and newborn screening.
• Environmental DNA Analysis: Expanding applications in environmental DNA analysis.

Major Market Trends

• Technological Advancements: Continuous technological advancements in sequencing technology.
• Next-Generation Sequencing Demand: Growing demand for next-generation sequencing.
• Clinical Diagnostics Applications: Increased use in clinical diagnostics.
• Genomics Research Investments: Rising investments in genomics research.
• Personalized Medicine: Expanding use in personalized medicine.

Impact of Genetic Illness Surge

• Genetic Illnesses: Rise in genetic illnesses propels market growth.
• Diagnostics: Sanger sequencing used for diagnosing genetic disorders.
• Rare Diseases: Over 7,000 known rare genetic diseases, affecting 30 million people in the US.

Key Companies in the Market

• Hoffmann-La Roche
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Eurofins Scientific
• Illumina Inc.
• Beckman Coulter
• PerkinElmer Inc.
• BGI Group
• LGC Limited
• GenScript
• Oxford Nanopore Technologies
• Pacific Biosciences of California Inc.
• Macrogen Inc.
• GENEWIZ Inc.

Advancements in Sanger Sequencing Technology

• Promega Corporation: Launched the ProDye Terminator Sequencing System in October 2021.
• System Features: Compatible with all capillary electrophoresis (CE) platforms, enhancing laboratory capabilities.
• Technological Edge: Uses proprietary thermostable DNA polymerase for high efficiency.

Strategic Acquisitions

• QIAGEN and Verogen: In January 2023, QIAGEN acquired Verogen for $150 million.
• Forensic Science: Strengthened leadership in forensic science.
• Market Reach: Enhanced market-leading sample extraction and library prep automation capabilities.

Market Segmentation

• By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing.
• By Laboratory: Wet Labs, Dry Labs.
• By Research: In-House, Outsourced.
• By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications.
• By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics.

Regional Insights

• North America: Largest region in the Sanger sequencing market in 2023.

The Sanger sequencing market is poised for significant growth, driven by technological advancements, expanding applications, and strategic acquisitions. With a strong presence in research, diagnostics, and personalized medicine, the market is set to transform various sectors, underscoring its critical role in advancing genomic science.

Request A Sample Of The Global Sanger Sequencing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13925&type=smp